All news

GMP for Atrix

GMP for Atrix

Drug delivery company Atrix Laboratories confirmed this week that
the German regulatory authority, Bundesinstitut fur Arzneimittel
und Medizinprodukte (BfArM), had recently completed a successful
inspection of Atrix's manufacturing...

FDA panel mulls cGMP issues

FDA panel mulls cGMP issues

As this edition of In-pharmatechnologist.com goes online, the US
Food and Drug Administration is convening the inaugural meeting of
its Advisory Committee for Pharmaceutical Science's Manufacturing
Subcommittee.

Extending plant powders

Extending plant powders

In the US this week, supplier of botanical extracts for the
pharmaceutical industry Pharmachem Laboratories announced that it
has acquired 'the largest botanical extraction facility in North
America, producing extracts for the...

Forum fuels knowledge in EU

Forum fuels knowledge in EU

An EU funded project is building the critical mass of knowledge
required to ensure that Europe meets the Lisbon objective of
becoming the world's most competitive knowledge-based economy by
2010, reports Cordis.

Biopharma merger in UK

Biopharma merger in UK

Spotlight on the home of the celebrated pork pie in England, with
the annoucement this week that Melton Mowbray-based Bridgehead
Technologies and Pharmalicensing - two biopharmaceutical business
development companies - are to merge.

D&E to offer outsourcing

D&E to offer outsourcing

US manufacturer of vitamins, minerals, herbs and supplements
D&E Pharmaceuticals, has launched a contract manufacturing
services initiative, principally aimed at small to medium sized
nutraceutical suppliers.

Cost cutting at Axis-Shield

Cost cutting at Axis-Shield

In a bid to improve efficiency and reduce costs UK in vitro
diagnostics company Axis-Shield is to shift the manufacture of
certain products from its site in Oslo, Norway to the company's
global headquarters in Dundee, Scotland.

Hope for FP6

Hope for FP6

Architects of the new instruments for the Sixth Framework Programme
will be heartened by news that a German report on the country's
networks of competence has concluded that such arrangements
stimulate innovation and, in turn,...

Modest growth for Balchem

Modest growth for Balchem

Balchem reported a small rise in net sales, up 3 per cent overall
during the first quarter of 2003, but said it was pleased with
results in light of the continued difficult economic environment.
Net earnings at the New York-based...

Towards 3 per cent GDP

Towards 3 per cent GDP

In a bid to increase European competitity in the global research
arena the European Commission announced new measures destined to
encourage public and private players across Europe to upgrade their
research effort.

New LPDE range from Rexam

New LPDE range from Rexam

UK packaging giant Rexam, a major producer of pharmaceutical
closures and one of the world's top five consumer packaging groups,
has introduced a range of LDPE and foil laminate bags and drum
liners manufactured in a cGMP compliant...

Cautious 2003 for DSM

Cautious 2003 for DSM

The global economic downturn marked 2003 first quarter results for
Dutch based life science company DSM but strong autonomous volume
growth boosted figures to higher than 2002.

Meeting GMP standards

Meeting GMP standards

Invensys APV, a supplier of process equipment to the pharmaceutical
industry, will demonstrate its new technologies at the upcoming
Achema 2003 exhibition in Frankfurt, Germany.

The new face of genomics

The new face of genomics

Prominent US genomics Robert L. Strausberg, who directs the
National Cancer Institute's (NCI) Cancer Genomics office, has been
named as vice president for research at The Institute for Genomic
Research (TIGR).

Strategies for biotech growth

Strategies for biotech growth

The biotechnology industry in the state of British Columbia in
Canada could double the number of companies, attract large
revenue-generating biotechnology firms and create more than 5,000
new jobs within five years, says a strategic...

Follow us

Webinars